Waltham, MA-based Thermo Fisher Scientific (NYSE:[[ticker:TMO]]), a major provider of lab instruments and services, aims to sell two of its lab test businesses in deals that could bring the firm in the neighborhood of $1 billion, Bloomberg News reported today, citing three anonymous sources. The two Thermo businesses on the block include Worcester, MA-based Athena Diagnostics and Lancaster Labs, in Lancaster, PA, people told Bloomberg. The potential sales are seen as Thermo Fisher’s strategy to de-emphasize its services business in favor of its lab instruments businesses.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
